PETV earnings analysis
What we found in PETV's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The provided 10-Q excerpt does not include the income statement, balance sheet, cash-flow statement, segment disclosures, or quantitative outlook, so revenue, margins, EPS, liquidity, and free-cash-flow trends cannot be assessed. The filing does disclose $750,000 of private-placement proceeds but also substantial equity issuance, including 937,500 placement shares, 368,152 employee-award shares, and 200,000 service-provider shares. The VetStem licensing agreement terminated on July 24, 2026, while OSHA-related risks remain identified as potentially material.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- $750,000 raised in private placement
- The company issued 937,500 common shares for $750,000 in private-placement proceeds during April and June 2026, providing additional financing liquidity.
- Preferred dividends converted to equity
- The company issued 176,174 common shares valued at $125,000 to convert dividends declared on Series B preferred stock, eliminating the stated dividend obligation through equity issuance.
- Equity compensation supported services
- The company issued 62,500 shares valued at $42,000 to 5 board members for advisory and consulting services, and 368,152 shares valued at $280,475 to 6 employees for performance awards.
- VetStem licensing agreement terminated
- The VetStem licensing agreement was terminated on July 24, 2026, following continued negotiations, representing a change in the company’s licensing arrangements.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Private-placement dilution
- The company issued 937,500 shares for $750,000 in a private placement, increasing the share count and creating dilution risk for existing holders.
- Additional equity compensation dilution
- The company issued 368,152 shares valued at $280,475 to 6 employees and 200,000 shares valued at $160,000 to a service provider during the quarter, indicating additional equity-based compensation and service costs.
- OSHA and licensing uncertainty
- The filing states that risks related to an OSHA complaint could materially affect the business, financial condition, and future results; the filing also states that the VetStem licensing agreement terminated on July 24, 2026.
What they said about what is next.
The provided 10-Q text does not disclose quantitative revenue or EPS guidance, and no outlook, liquidity outlook, or capital-spending forecast is included.
The filing reads about the same as the one before it.
What came before.
- 10-K · June 29, 2026
- PetVivo Holdings reported revenues of $1,141,607 for fiscal year ending March 31, 2026, virtually unchanged from $1,132,533 in the prior year. However, the company continues to incur substantial losses, recording a net…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing PETV makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever